← Back to Search

ECIG Lab Session, 30 watts for Vaping

N/A

Waitlist Available

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this measure will be administered at approximately 90, 100, 120, 190, and 205 minutes.

Awards & highlights

Study Summary

This trial will test how different nicotine levels in e-cigarettes affects smokers.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this measure will be administered at approximately 90, 100, 120, 190, and 205 minutes.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this measure will be administered at approximately 90, 100, 120, 190, and 205 minutes.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this measure will be administered at approximately 90, 100, 120, 190, and 205 minutes. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cigarette Challenge Paradigm

Plasma Nicotine Concentration

Secondary outcome measures

Puff duration

Puff volume

Other outcome measures

Change in heart rate

Direct Effects of Nicotine Questionnaire

Direct Effects of Vaping Questionnaire

+5 more

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Cigarette Smokers: 4 mg/ml nicotine concentrationExperimental Treatment1 Intervention

ECIG Lab Session, 30 watts, 6 mg/ml nicotine concentration During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

Group II: Cigarette Smokers: 30 mg/ml nicotine concentrationExperimental Treatment1 Intervention

ECIG Lab Session, 30 watts, 30 mg/ml nicotine concentration During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

Group III: Cigarette Smokers: 15 mg/ml nicotine concentrationExperimental Treatment1 Intervention

ECIG Lab Session, 30 watts, 15 mg/ml nicotine concentration During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

Group IV: Cigarette Smokers: 0 mg/ml nicotine concentrationActive Control1 Intervention

ECIG Lab Session, 30 watts, 0 mg/ml nicotine concentration During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

697 Previous Clinical Trials

22,884,964 Total Patients Enrolled

Alison Breland, PhDStudy DirectorVirginia Commonwealth University

9 Previous Clinical Trials

445 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

clinicaltrials.govStudy

Assessing Electronic Cigarette Nicotine Flux

2021. "Assessing Electronic Cigarette Nicotine Flux". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04378907.

~8 spots leftby Apr 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.